Photobiomodulation Therapy and Transcutaneous Electrical Nerve Stimulation on Chronic Neck Pain Patients
CompletedNot applicableNCT04020861
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates the efficacy isolated and combinaded of photobiomodulation therapy with low level laser therapy and the transcutaneous electrical nerve stimulation.
Study details
- Official title
- Photobiomodulation Therapy and Transcutaneous Electrical Nerve Stimulation on Chronic Neck Pain Patients
- Conditions
- Interventions
- Device: Active PBM
- Device: Active TENS
- Device: Placebo PBM
- Device: Placebo TENS
- Sponsor
- Universidade Federal de Sao Carlos
- Collaborators
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Start date
- 2020-01-06
- Primary completion
- 2021-06-25
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with non-specific chronic neck pain, defined as pain or discomfort in the posterior cervical region between the superior nuchal line and the first thoracic spinous process and / or shoulder girdle; * Neck pain for at least 3 months; * Neck Disability Index (NDI) score of 5 points or higher; * Numeric Rating Scale (NRS) score of 3 or higher to pain intensity; * Aged between 18 and 65 years; * Men and women Exclusion Criteria: * Neck pain associated with nerve root compromise (measured by clinical examination of dermatomes, myotomes and reflexes); * Previous spinal surgery; * Patients treated with physical therapy for neck pain in the last 3 months previous the study; * Severe spinal disorders such as fractures, tumors, inflammatory and infectious diseases; * Any contraindication to low level laser therapy or transcutaneous electrical nerve stimulation; * Rheumatic, metabolic, neurological or cardiopulmonary diseases; * Patients who require artificial cardiac pacemakers; * Skin diseases, mainly at the current application site; * Tumors or cancer historic in the last 5 years; * Pregnancy; * If the patient started any physical activity in the last 2 weeks.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04020861